Русский

Pharmaceutical Industry Information Portal

HomeTagsRDIF

All posts by tag

RDIF

Russian Direct Investment Fund (RDIF)

The Russian Direct Investment Fund (RDIF) is Russia’s sovereign wealth fund established in 2011 by the Russian government to make investments in leading companies of high-growth sectors of the Russian economy. Its mandate is to co-invest alongside the world’s largest institutional investors — direct investment funds, sovereign wealth funds and leading companies. RDIF therefore acts as a catalyst for direct investment in Russia. RDIF’s reserved capital under management equals $10 billion.

Discovery and Development

One shot Sputnik Light has high safety and 93.5% efficacy against COVID

Techno -
The heterogeneous boosting approach was at the core of Sputnik V, the world’s first registered vaccine against coronavirus.
Manufacturers News

Laboratorios Richmond delivers the first batch of over 1M doses of the Sputnik V produced in Argentina

Techno -
Locally produced Sputnik V was supervised and verified by the National Administration of Drugs, Foods and Medical Devices of Argentina (ANMAT).
Discovery and Development

Combination of the Sputnik Light with others vaccines demonstrates high safety profile

Techno -
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.
Manufacturers News

Laboratorios Richmond to provide with over 3 million doses of the second component of the Sputnik V vaccine

Techno -
RDIF and partners facilitated the technology transfer to Laboratorios Richmond for the local production of the vaccine with the first batch manufactured in April 2021.
Manufacturers News

Kazakhstan’s Karaganda pharmaceutical plant ready to manufacture Sputnik Light vaccine

Techno -
By now, the Karaganda plant has manufactured five million doses of the Sputnik V vaccine.
Discovery and Development

The combination between the AstraZeneca vaccine and the Sputnik Light shows no serious adverse events

Techno -
In August 2021, RDIF and partners will publish initial data on the immunogenicity of the combined use of the AstraZeneca vaccine and the Sputnik V vaccine in Azerbaijan.
123...5Page 2 of 5
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories